TC BioPharm (Holdings) plc (CIK: 0001872812) EDGAR, Information, Filings... CompaniesBIO.Com

TC BioPharm (Holdings) plc

Mailing address
MAXIM 1, 2 PARKLANDS WAY, HOLYTOWN, X0, ML1 4WR
Phone
01414337557
State location
United Kingdom
State of incorporation
N/A
Fiscal year end
December 31
SIC
2836 - (CF Office: Office of Life Sciences) BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Filings
N/A

TC BioPharm (Holdings) plc (CIK: 0001872812) is an American company incorporated in the state of United Kingdom. Head office is located at MAXIM 1, 2 PARKLANDS WAY, HOLYTOWN, United Kingdom, ML1 4WR. Work in the industry 2836 - (CF Office: Office of Life Sciences) BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES). TC BioPharm (Holdings) plc is a public company and trade via Over-The-Counter (OTC).

Old names:

TC BioPharm (Holdings) Ltd from 2021-26-Jul to 2021-23-Dec

Owner	Filings	Transaction Date	Type of Owner
Randall Mark Edward	0001916323	Nov-30-2022	10 percent owner
Randall Kenneth Edward	0001929926	Nov-30-2022	10 percent owner
Randall Diana Elizabeth	0001917012	Feb-10-2022	10 percent owner
Renaissance Capital Partners Ltd	0001920179	Feb-10-2022	10 percent owner

Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by TC BioPharm (Holdings) plc

Filings	Format	Description	Filed/Effective	File/Film Number
6-K	Document	Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0001493152-24-033702 (34 Act) Size: 19 KB	Aug-23-2024	001-41231 241236282
F-1	Document	Registration statement for securities of certain foreign private issuers Acc-no: 0001493152-24-032827 (33 Act) Size: 1119 KB	Aug-16-2024	333-281613 241216979
6-K	Document	Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0001493152-24-032528 (34 Act) Size: 530 KB	Aug-15-2024	001-41231 241211033
424B4	Document	Prospectus filed pursuant to Rule 424(b)(4) Acc-no: 0001493152-24-031860 (33 Act) Size: 904 KB	Aug-14-2024	333-280659 241204173
EFFECT	Document	Acc-no: 9999999995-24-002500 (33 Act) Size: 1 KB	Aug-12-2024	333-280659 241198598
F-1/A	Document	Amendment to Registration statement for securities of certain foreign private issuers Acc-no: 0001493152-24-030881 (33 Act) Size: 1722 KB	Aug-09-2024	333-280659 241190655
6-K	Document	Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0001493152-24-030796 (34 Act) Size: 73 KB	Aug-08-2024	001-41231 241188935
6-K	Document	Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0001493152-24-030413 (34 Act) Size: 23 KB	Aug-06-2024	001-41231 241179090
6-K	Document	Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0001493152-24-029416 (34 Act) Size: 32 KB	Jul-29-2024	001-41231 241152305
F-1	Document	Registration statement for securities of certain foreign private issuers Acc-no: 0001493152-24-026004 (33 Act) Size: 1085 KB	Jul-02-2024	333-280659 241095150
6-K	Document	Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0001493152-24-025802 (34 Act) Size: 795 KB	Jul-01-2024	001-41231 241091050
6-K	Document	Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Acc-no: 0001493152-24-025790 (34 Act) Size: 658 KB	Jul-01-2024	001-41231 241090523
8-K	Document	Current report filing Acc-no: 0001493152-24-025622 (34 Act) Size: 258 KB	Jun-28-2024	001-41231 241086179
424B3	Document	Prospectus filed pursuant to Rule 424(b)(3) Acc-no: 0001493152-24-025262 (33 Act) Size: 893 KB	Jun-26-2024	333-280000 241073455
EFFECT	Document	Acc-no: 9999999995-24-001928 (33 Act) Size: 1 KB	Jun-24-2024	333-280000 241066063
CORRESP	Document	A correspondence can be sent as a document with another submission type or can be sent as a separate submission. Acc-no: 0001493152-24-024501 ( Act) Size: 11 KB	Jun-20-2024
S-3/A	Document	Amendment to Registration statement for specified transactions by certain issuers Acc-no: 0001493152-24-024499 (33 Act) Size: 1092 KB	Jun-20-2024	333-280000 241056218
UPLOAD	Document	Acc-no: 0000000000-24-006678 ( Act) Size: 39 KB	Jun-11-2024	333-280000
DEF 14A	Document	Definitive proxy statements Acc-no: 0001493152-24-023099 (34 Act) Size: 2223 KB	Jun-07-2024	001-41231 241029297
S-3	Document	Registration statement for specified transactions by certain issuers Acc-no: 0001493152-24-022939 (33 Act) Size: 1204 KB	Jun-06-2024	333-280000 241025333

Recent 20 filings. View all TC BioPharm (Holdings) plc filings

Overall rating 5.0

Aug 22, 2022

Samuel Ejimofor

It's being easier working on the website. And I recommend, it's a great website

Aug 22, 2022

Jean Bishop

Very good communication and delivery made within the timeframe I was advised of

Aug 22, 2022

Catherine

Thanks I look forward to using the product to improve my skin tone

TC BioPharm (Holdings) plc overview
TC BioPharm (Holdings) plc job
TC BioPharm (Holdings) plc stock
TC BioPharm (Holdings) plc ownership
TC BioPharm (Holdings) plc CEO
TC BioPharm (Holdings) plc documents

Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.